Skip to main content
logo
Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.1500
-0.0050 (-3.23%)
Aug 5, 2026, 1:04 PM AEST

Argenica Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-9.8-7.17-5.48-4.82-4.09-1.03
Stock-Based Compensation
0.110.110.140.460.430.27
Change in Accounts Receivable
-0.03-0.03-0.23-0.07-0-0.09
Change in Accounts Payable
1.471.470.450.460.29-0.2
Change in Unearned Revenue
-0.09-0.090.050.66--
Change in Other Net Operating Assets
0.010.010.020.010.020.01
Operating Cash Flow
-10.04-5.7-5.06-3.3-3.36-1.05
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Investment in Securities
--0.05-0.05--
Investing Cash Flow
--0.05-0.05--

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Issuance of Common Stock
-0.3511.633.735.137.85
Other Financing Activities
0.02--000
Financing Cash Flow
00.3511.633.735.137.85

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Cash Flow
-10.04-5.366.620.371.776.8

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Levered Free Cash Flow
-6.57-3.34-3.11-1.52-1.82-0.4
Unlevered Free Cash Flow
-6.57-3.34-3.11-1.52-1.82-0.4

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Interest Paid
000000
Cash Income Tax Paid
--2.76-2.09-1.38-0.26-0.15
Change in Working Capital
1.361.360.281.050.3-0.29